Transfusion confusion: hemolysis or eltrombopag?

Szczegóły

Tytuł:: Transfusion confusion: hemolysis or eltrombopag?
Autorzy:: Zakieh A; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
Moayeri M; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
Źródło:: Transfusion [Transfusion] 2020 Feb; Vol. 60 (2), pp. 235-236. Date of Electronic Publication: 2019 Nov 24.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Arlington, Va. : American Association Of Blood Banks
MeSH Terms:: Benzoates/*therapeutic use
Blood Transfusion/*methods
Hemolysis/*physiology
Hydrazines/*therapeutic use
Pyrazoles/*therapeutic use
Aged ; Bilirubin/metabolism ; Female ; Hemoglobins/metabolism ; Hemolysis/drug effects ; Humans ; L-Lactate Dehydrogenase/metabolism
References:: National Healthcare Safety Network Biovigilance Component, Hemovigilance module surveillance protocol [cited 2019 Sep 27]. Available from: https://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf.
West KA, Leitman SF, Flegel WA. Muddy waters in therapeutic plasma exchange. Transfusion 2014;54:2157.
Cardamone D, Milone MC, Glaser L, et al. Eltrombopag and serum of a different hue. Arch Pathol Lab Med 2013;137:1175.
Adams DF, Sellers TS. Eltrombopag: investigation of previously reported serum discoloration and negative interference on a total bilirubin diazo method. Arch Pathol Lab Med 2016;140:391-2.
Gounden V, Zhao Z. Eltrombopag interference in routine chemistry testing. Ann Clin Biochem 2016;53:611-4.
Choy KW, Wijeratne N, Doery JCG. Eltrombopag: liver toxicity, kidney injury or assay interference? Pathology 2016;48:754-6.
Brecher ME, Hay SN. Pseudohemolysis with iron dextran therapy. Transfusion 2002;42:135.
Wong SL, Pudek M, Li D. Wine-colored plasma and urine from hydroxocobalamin treatment. J Gen Intern Med 2016;32:225-6.
Zhao X, Yoon EJ, Zantah M, et al. Discoloration of plasma associated with atovaquone in therapeutic plasma exchange. J Clin Apher 2019;34:480-1.
Tesfazghi MT, MR MG, Yarbrough ML. What's causing this dark brown plasma? J Appl Lab Med 2019;04:125-9.
Korte EA, Pozzi N, Wardrip N, et al. Analytical interference of HBOC-201 (Hemopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms. Clin Chim Acta 2018;482:33-9.
Substance Nomenclature:: 0 (Benzoates)
0 (Hemoglobins)
0 (Hydrazines)
0 (Pyrazoles)
EC 1.1.1.27 (L-Lactate Dehydrogenase)
RFM9X3LJ49 (Bilirubin)
S56D65XJ9G (eltrombopag)
Entry Date(s):: Date Created: 20191126 Date Completed: 20200907 Latest Revision: 20200907
Update Code:: 20240104
DOI:: 10.1111/trf.15608
PMID:: 31762041
: Czasopismo naukowe

Full Text Finder

Informacja